Oncology clinical trials require significantly robust support from start to end from your CRO partner. In contrast to other therapeutic areas, oncology poses special challenges when it comes to selecting the right investigator sites, laboratories, imaging facilities, and study teams. A fail-safe implementation strategy is critical for the success of each oncology clinical trial across the different phases of the clinical development process. We work closely with our clients to fully understand the unique needs of their development process. The needs of a biotechnology company that requires the securing of further investment or out-licensing the asset can be different from a mid-size or large pharmaceutical company developing their oncology drug.

Clinexa team has deep experience in planning and implementation of complex oncology studies. We have experience in multiple areas within oncology including immune-oncology studies. For each oncology study, we ensure that the Project Manager (PM) and Site Monitors have extensive experience in oncology studies, and specially in the indication that the specific study is focused.

For early phase oncology studies, Clinexa ensures that we stay time-critical for all aspects of the studies so that our clients are able to reach their study milestones earlier than expected or on time as per their plans. We do this through an concerted team work across our clinical project team for the study. We work with dedicated facilities or very experienced oncology centers that have shown past success in conducting early phase oncology studies. With the support of our technology platforms for EDC and Data visualization, we area able to be nimble and resourceful for speedy start-up and efficient recruitment for oncology studies.